Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Surgical Oncology|May 16, 2018
Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy ConsortiumAlexandra G Lopez-Aguiar, Cecilia G Ethun, Mia R McInnis, et al.
Neuroendocrinology|February 11, 2020
Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Amika Moro, et al.
Annals of Surgical Oncology|March 29, 2020
Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine TumorsPaula Marincola Smith, Jordan Baechle, Marcus C Tan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2019
Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine TumorsAlexander V Fisher, Alexandra G Lopez-Aguiar, Victoria R Rendell, et al.
The American Surgeon|July 26, 2017
Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy ConsortiumCecilia G Ethun, Nina Le, Alexandra G Lopez-Aguiar, et al.
Annals of Surgery|August 1, 2018
Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional StudyVikrom K Dhar, Nipun B Merchant, Sameer H Patel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 11, 2020
Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumorsCharlotte M Heidsma, Diamantis I Tsilimigras, Susan van Dieren, et al.
Annals of Surgery|October 25, 2017
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable DiseaseCecilia G Ethun, Alexandra G Lopez-Aguiar, Douglas J Anderson, et al.
Pageof 6